Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HealthLynked (HLYK) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for HealthLynked (HLYK) over the last 10 years, with Q3 2025 value amounting to -$529586.0.

  • HealthLynked's Income towards Parent Company rose 6831.38% to -$529586.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.8 million, marking a year-over-year increase of 2841.34%. This contributed to the annual value of -$6.1 million for FY2024, which is 33566.77% down from last year.
  • Latest data reveals that HealthLynked reported Income towards Parent Company of -$529586.0 as of Q3 2025, which was up 6831.38% from -$435385.0 recorded in Q2 2025.
  • In the past 5 years, HealthLynked's Income towards Parent Company ranged from a high of $2.6 million in Q1 2023 and a low of -$7.8 million during Q1 2021
  • Over the past 5 years, HealthLynked's median Income towards Parent Company value was -$435385.0 (recorded in 2025), while the average stood at -$820431.2.
  • Its Income towards Parent Company has fluctuated over the past 5 years, first soared by 185161.02% in 2023, then crashed by 473146153.85% in 2024.
  • HealthLynked's Income towards Parent Company (Quarter) stood at -$2.0 million in 2021, then skyrocketed by 90.17% to -$196909.0 in 2022, then surged by 99.99% to -$26.0 in 2023, then crashed by 4731461.54% to -$1.2 million in 2024, then skyrocketed by 56.95% to -$529586.0 in 2025.
  • Its Income towards Parent Company was -$529586.0 in Q3 2025, compared to -$435385.0 in Q2 2025 and -$617389.0 in Q1 2025.